BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8760292)

  • 61. Stabilization of c-myc protein in human glioma cells.
    Shindo H; Tani E; Matsumuto T; Hashimoto T; Furuyama J
    Acta Neuropathol; 1993; 86(4):345-52. PubMed ID: 8256584
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MUC1-C drives MYC in multiple myeloma.
    Tagde A; Rajabi H; Bouillez A; Alam M; Gali R; Bailey S; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D
    Blood; 2016 May; 127(21):2587-97. PubMed ID: 26907633
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A complex pattern of translational initiation and phosphorylation in L-myc proteins.
    Dosaka-Akita H; Rosenberg RK; Minna JD; Birrer MJ
    Oncogene; 1991 Mar; 6(3):371-8. PubMed ID: 1849244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. c-myc transcription is initiated from P0 in 70% of patients with multiple myeloma.
    Hoover RG; Kaushal V; Lary C; Travis P; Sneed T
    Curr Top Microbiol Immunol; 1995; 194():257-64. PubMed ID: 7895497
    [No Abstract]   [Full Text] [Related]  

  • 65. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
    Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
    Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mRNAs for cyclin A, c-myc and ribosomal proteins L4 and S6 are associated with cytoskeletal-bound polysomes in HepG2 cells.
    Hovland R; Campbell G; Pryme I; Hesketh J
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):193-6. PubMed ID: 7646444
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.
    Jiang Y; Saga K; Miyamoto Y; Kaneda Y
    Oncotarget; 2016 Jun; 7(24):36034-36048. PubMed ID: 27145280
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro.
    Lee CH; Leeds P; Ross J
    J Biol Chem; 1998 Sep; 273(39):25261-71. PubMed ID: 9737991
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia: an in situ analysis.
    Greil R; Fasching B; Loidl P; Huber H
    Blood; 1991 Jul; 78(1):180-91. PubMed ID: 2070052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gm6377 suppressed SP 2/0 xenograft tumor by down-regulating Myc transcription.
    Zhai B; Hou C; Xu R; Fang Y; Ma N; Xing C; Wang X; Xiao H; Chen G; Han G; Wang R
    Clin Transl Oncol; 2020 Sep; 22(9):1463-1471. PubMed ID: 31950438
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transcription-independent functions of MYC: regulation of translation and DNA replication.
    Cole MD; Cowling VH
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):810-5. PubMed ID: 18698328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells.
    Nobuyoshi M; Kawano M; Tanaka H; Ishikawa H; Tanabe O; Iwato K; Asaoku H; Sakai A; Kuramoto A
    Br J Haematol; 1991 Apr; 77(4):523-8. PubMed ID: 2025578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts.
    Rygaard K; Vindeløv LL; Spang-Thomsen M
    Int J Cancer; 1993 Apr; 54(1):144-52. PubMed ID: 8386707
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant.
    Bernstein PL; Herrick DJ; Prokipcak RD; Ross J
    Genes Dev; 1992 Apr; 6(4):642-54. PubMed ID: 1559612
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Amylase-producing plasma cell dyscrasia. Genomic analysis in a case of intramuscular tumor formation and a review of the literature].
    Hirota K; Waga K; Nagashima S; Waku S; Yamazaki T; Saito K; Furusawa S; Shishido H
    Rinsho Ketsueki; 1993 Feb; 34(2):177-82. PubMed ID: 7684094
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.
    Wall M; Poortinga G; Hannan KM; Pearson RB; Hannan RD; McArthur GA
    Blood; 2008 Sep; 112(6):2305-17. PubMed ID: 18621930
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer.
    Kovalski JR; Xu Y; Ruggero D
    Methods Mol Biol; 2021; 2318():255-266. PubMed ID: 34019295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Localisation of a reporter transcript by the c-myc 3'-UTR is linked to translation.
    Dalgleish GD; Veyrune JL; Accornero N; Blanchard JM; Hesketh JE
    Nucleic Acids Res; 1999 Nov; 27(22):4363-8. PubMed ID: 10536143
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A correlation of APC and c-myc mRNA levels in lung cancer cell lines.
    Jaiswal AS; Kennedy CH; Narayan S
    Oncol Rep; 1999; 6(6):1253-6. PubMed ID: 10523691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of Myc-induced protein synthesis in cancer.
    Ruggero D
    Cancer Res; 2009 Dec; 69(23):8839-43. PubMed ID: 19934336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.